Peptide Drug Discovery Market Size, Share and Trends Report 2026 to 2035

Report Id: 2510 Pages: 180 Last Updated: 07 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Peptide Drug Discovery Market -

Peptide Drug Discovery Market by Type of Product -

  • Synthetic peptides
  • Biological peptides
  • Recombinant peptides
  • Macrocycles peptides

Peptide Drug Discovery Market Segmentation Analysis

Peptide Drug Discovery Market by Drug Discovery Steps  -

  • Target Identification and Validation
  • Hit Identification
  • Lead Generation 
  • Lead Optimization

 Peptide Drug Discovery Market by Therapeutic Area -

  • Oncological disorders
  • Metabolic disorders
  • Cardiovascular disorders
  • Infectious disorders
  • Urological disorders
  • Endocrine disorders
  • CNS disorders
  • Other diseases                     

Peptide Drug Discovery Market by Company Size -

  • Small
  • Mid-sized
  • Large and very large

Peptide Drug Discovery Market by Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Peptide Drug Discovery Market Snapshot

Chapter 4. Global Peptide Drug Discovery Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Type of Product Estimates & Trend Analysis

5.1. by Type of Product & Market Share, 2025 & 2035

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Type of Product:

5.2.1. Synthetic Peptides

5.2.2. Biological Peptides

5.2.3. Recombinant Peptides

5.2.4. Macrocycles Peptides

Chapter 6. Market Segmentation 2: by Drug Discovery Steps Estimates & Trend Analysis

6.1. by Drug Discovery Steps & Market Share, 2025 & 2035

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Drug Discovery Steps:

6.2.1. Target Identification and Validation

6.2.2. Hit Identification

6.2.3. Lead Generation  

6.2.4. Lead Optimization

Chapter 7. Market Segmentation 3: by Therapeutic Area Estimates & Trend Analysis

7.1. by Therapeutic Area & Market Share, 2025 & 2035

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Therapeutic Area:

7.2.1. Oncological disorders

7.2.2. Metabolic disorders

7.2.3. Cardiology Surgery

7.2.4. Neurology

7.2.5. Cardiovascular disorders

7.2.6. Infectious disorders

7.2.7. Urological disorders

7.2.8. Endocrine disorders

7.2.9. CNS disorders

7.2.10. Other diseases

Chapter 8. Market Segmentation 4: by Company Size Estimates & Trend Analysis

8.1. by Company Size & Market Share, 2025 & 2035

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2022 to 2035 for the following by Company Size:

8.2.1. Small

8.2.2. Mid-Sized

8.2.3. Large and very large

Chapter 9. Peptide Drug Discovery Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035

9.1.2. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035

9.1.3. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035

9.1.4. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035

9.1.5. North America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035

9.2. Europe

9.2.1. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035

9.2.2. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035

9.2.3. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035

9.2.4. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035

9.2.5. Europe Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035

9.3. Asia Pacific

9.3.1. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035

9.3.2. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035

9.3.3. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035

9.3.4. Asia-Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035

9.3.5. Asia Pacific Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035

9.4. Latin America

9.4.1. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035

9.4.2. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035

9.4.3. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035

9.4.4. Latin Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035

9.4.5. Latin America Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035

9.5. Middle East & Africa

9.5.1. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Type of Product, 2022 - 2035

9.5.2. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Drug Discovery Steps, 2022 - 2035

9.5.3. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2022 - 2035

9.5.4. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by Company Size, 2022 - 2035

9.5.5. Middle East & Africa Peptide Drug Discovery Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. GenScript 

10.2.2. JPT Peptide Technologies 

10.2.3. CPC Scientific  

10.2.4. IRBM 

10.2.5. Creative Peptides

10.2.6.  Pepscan

10.2.7. Peptides and Macrocycle Drug Discovery Platform Providers

10.2.8. RA Pharmaceuticals

10.2.9.  Pepticom 

10.2.10. PeptiDream

10.2.11. Creative Biolabs

10.2.12. MeSCue-Janusys

10.2.13. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5987
Security Code field cannot be blank!

Frequently Asked Questions

Peptide Drug Discovery Market Size is valued at 810.85 Mn in 2025 and is predicted to reach 2,481.57 Mn by the year 2035.

Peptide Drug Discovery Market is predicted to develop at an 12.2% CAGR during the forecast period for 2026-2035.

CPC Scientific, IRBM, Creative Peptides, Pepscan, Peptides and Macrocycle Drug Discovery Platform, Providers, RA Pharmaceuticals, Pepticom, PeptiDream

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying